Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Grows By 20.0%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 600 shares, an increase of 20.0% from the November 30th total of 500 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently 1.2 days.

Mosaic ImmunoEngineering Stock Performance

CPMV remained flat at $0.70 on Monday. 324 shares of the company were exchanged, compared to its average volume of 898. The firm has a market capitalization of $5.08 million, a P/E ratio of -4.67 and a beta of 0.15. Mosaic ImmunoEngineering has a one year low of $0.10 and a one year high of $1.13. The firm has a 50 day moving average price of $0.90 and a two-hundred day moving average price of $0.84.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.